|
Post by stevil on Nov 9, 2015 19:50:56 GMT -5
236 million<708 million
It's sad that business is run this way, but it's like VW. They'd rather pay the fines because it's cheaper than the cost of business.
Hopefully SNY isn't sandbagging Afrezza also, although it sure looks that way.
|
|
|
Post by stevil on Nov 9, 2015 19:40:50 GMT -5
What's the point of going all in on the DTC if there's roadblocks in the way? Do you have any idea how hard it still is to get an Afrezza script? Until Tier 2 is fully achieved, and these script delay problems are resolved, you're not going to see a full blown entry into the market, (DTC), by Sanofi. Yes, Denise. Go back and read my first few posts. I actually said all that you said now too. I was a pharmacy tech for 8 years. I understand the physician/insurance/patient dynamic maybe better than anyone on here. It's why I was so adamant about tempering people's expectations...
|
|
|
Post by stevil on Nov 9, 2015 19:34:16 GMT -5
Excuse me but you state that your neg opinions have been correct? How can you state that? This is far from over and conclusions are yet to be drawn, but if you feel otherwise that your neg opinions are now fact, well I guess that's just another opinion of yours. Thank you for your reply, Denise. My negative opinions have been validated by the share price. I call it like I see it. When things start getting better, I'll have better things to say and analyze. If you want to go back to one of my first posts in June, I was one of the first people on here to say that this will take a long time. I was one of the first to say that commercials wouldn't come out until a label change. I got slammed for it back then. Now it seems like popular opinion. It's hard to go back and see that because there are so many posts between now and then, but I remember distinctly the first few posts I had on here. I don't want to come across as a know-it-all, although I know that's a weakness of me and my writing style. I have money invested in this company like the rest of you all. I want it to succeed. I'm in medical school and sacrificing years and HUGE dollars for the betterment of people's lives through medicine. It's what drew me to Afrezza in the first place. But once I saw the cult following and the culture on this board, I guess you could say that it was partially my mission to help objectify the board. This board and Afrezza have become as much of people's daily lives as food, work, and family. They're attached to it. Perhaps it was improper of me to worry about the well-being of a stranger and their financial well-being, but I wanted to help shed more light on what I believe the truth of the matter is regarding Afrezza. I've been on break the last week so I had more time to post, but I see that I'm not popular around here. Fortunately, winter quarter is pretty demanding so I'll be lurking more than posting
|
|
|
Post by stevil on Nov 9, 2015 19:08:48 GMT -5
Pardon the pun, but after this call I think we are no longer a billion dollar company. (Sad face) Yeah no kidding. Congratulations Matt and Hakan. Will you accept a $1 salary like the Lilly CEO did when it's stock was in the dumpster? Something to think about. Wow. Just amazing at how over a billion of market cap can evaporate. Actually more than that, all in just a few months. Come on guys. Seriously, if you don't want to do the job or can't do it, just let somebody else do it. It's a free country. Freer for some than others, of course. My fear is they cannot afford to pay the right people (people with proven resumes) their asking price to run this company. So we're either stuck with what we've got or we pick someone with a lot of potential that may not have a lot of experience and hope for the best.
|
|
|
Post by stevil on Nov 9, 2015 19:07:32 GMT -5
Al seems to have confidence in Hakan. What does that tell you? It tells me that Hakan is probably very efficient at most other aspects of his job, just not the kind of guy you want explaining stuff away. And Stevil, please do not Like my posts. I have nothing buy contempt for your opinions. Noted. And won't do that again. Not sure why you feel so strongly about it. Feel free to call out anything I've said that hasn't been at least in the general vicinity of the right direction. Don't take your anger out on me because my opinions have been negative but correct. I guess I'll add more gasoline to the fire and say you and patryn are some of the posters I most look forward to reading.
|
|
|
Post by stevil on Nov 9, 2015 19:03:40 GMT -5
Hakan opened his part begging for a partner - they will have a field day with that one. Wild speculation on my part but maybe it was Hakan's clever way to send a message to Sanofi that Mannkind has another willing partner if Sanofi doesn't pick things up. No, just no. MNKD has the cards, but SNY owns all the chips. Don't be fooled in who has the power right now. SNY doesn't need MNKD. MNKD needs SNY until someone else comes along. SNY wouldn't lose a second of sleep over losing MNKD. But they will lose millions more by keeping them.
|
|
|
Post by stevil on Nov 9, 2015 18:56:58 GMT -5
I am with you EOTD.
People who have no plan cannot cast a vision. People with a plan have plan A, B, and C already lined up in case one falls through. That we haven't even heard a solid plan A is troubling to me. It doesn't behoove MNKD to have secrets at this point, or probably ever. We need every bit of momentum we can get right now to drive the SP and cash up. If there was any good news, I think they'd have divulged it.
|
|
|
Post by stevil on Nov 9, 2015 18:48:34 GMT -5
That he's still human and can make mistakes. You guys give Al god status around here.
Edit to add:
Are you guys really that impressed with Hakan to think that better can't/doesn't exist out there? Quit with your blind faith and think for yourselves ha. A bunch of sheep on this board!
|
|
|
Post by stevil on Nov 9, 2015 18:41:54 GMT -5
Chris-C,
To be honest with you, preparation has a lot to do with planning. I don't know how many public speaking gigs you've done, but I know I'm a much,much better speaker when I'm knowledgeable about what I'm talking about. I have more confidence. I don't stumble. I have an answer ready because I've already done all the preparation needed to anticipate.
I think the biggest problem with Matt/Hakan is that they're either handcuffed in what they can say/do or they just lack the organizational and visionary skills needed to run a billion dollar company. It's really hard to know where to place the blame, but one would think it must fall directly on their shoulders at some point. If SNY isn't doing what they want or expect from them, they need to be proactive and find a better partner. If they realize that no one wants their "blockbuster" drug, they need to then fully invest in the "embarrassment of riches" and quit wasting time, money, and energy on Afrezza. If it's insurance coverage, then get the deals done already. Time is money.
I just don't have confidence in these guys that they have what it takes to run this company. Too many holes that have been evident for too many months. Other companies are getting the job done. It's possible.
|
|
|
Post by stevil on Nov 9, 2015 18:36:46 GMT -5
xoxoxoxo,
That's a great idea. I wonder if it's possible to sell one of our developed drugs or if they're somehow trying to protect the FDKP technology. Seems like with how skilled chemists are nowadays that this wouldn't be hard to retroactively solve, but they'd still have to sell the process of making everything. Also wonder about how patent infringements would work. But I hope for our sake it's possible, at the very least as a last resort.
|
|
|
Post by stevil on Nov 9, 2015 18:10:39 GMT -5
I'll add my unpopular opinion here.
2 things strike me as odd with the SNY partnership.
Why haven't they bought in yet?
1. They either knew that the SP was going to keep dropping so they waited until the "right time" to buy in.
or
2. They're not really invested in assuring Afrezza succeeds.
My brain is typically black/white, so hopefully someone from the rose colored glasses crowd can provide some of their radiance.
I'm truly not a basher and I'm not even going to be an "I told you so" kind of person. I hope that my reputation on this board will be one of due diligence and objectivity. And I'm pleased (bittersweetly I might add) that some of the emotional blindness most had is now being revealed. Why some continue to buy large blocks still baffles me. You have more money to lose than me haha.
Best of luck to all, but especially longs.
|
|
|
Post by stevil on Oct 30, 2015 20:53:00 GMT -5
Ya, I'm not buying either. What's the point in deceiving? SNY's stock price goes down, confidence in their diabetes plan goes down... You want to hype up a new drug as much as you can to maximize exposure. It's counterintuitive for them to sandbag. I'm not sure why so many people are in love with these kinds of theories. How does it give SNY an upper-hand in competition? It's not like the other companies aren't aware that Afrezza exists...
|
|
|
Post by stevil on Oct 17, 2015 14:24:06 GMT -5
Meaning no disrespect; but you sure don't sound like a Long to me at least. Aloha. Lol
|
|
|
Post by stevil on Oct 16, 2015 17:20:02 GMT -5
Original poster.
|
|
|
Post by stevil on Oct 16, 2015 14:21:41 GMT -5
What OP is saying, if he thinks about it, is one pharma company freaking out because another pharma company is releasing a new tablet of medication. The market is so huge that it will be several years or decades before competition starts to matter as it pertains to inhalants. Either a sizeable or the entire market shifts over to inhaled medicines, or it stays a niche product. Either way, MNKD will not be affected negatively in the near term.
Agree with jpg here. Any exposure to inhaled medicine right now is favorable to MNKD. We WANT Drs to start thinking this way. Then, once we gain momentum, we won't want any more competition. But we need it right now to get the ball rolling...
|
|